The bill
Lower Health Care Premiums for All Americans Act
HR. 6703, 119th Congress — read as touching Pharmaceuticals.
Lower Health Care Premiums for All Americans Act
Download PDFBill ID: 119/hr/6703
Last Updated: April 7, 2026
Sponsored by
Rep. Miller-Meeks, Mariannette [R-IA-1]
ID: M001215
Follow the money
The sponsor
Rep. Miller-Meeks, Mariannette [R-IA-1]
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
$166,100 raised
25 itemised contributions to this sponsor, pulled from FEC filings.
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Received in the Senate.
December 17, 2025
Introduced
Committee Review
Floor Action
Passed House
Senate Review
📍 Current Status
Next: Both chambers must agree on the same version of the bill.
🎉
Passed Congress
🖊️
Presidential Action
⚖️
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 6703 Engrossed in House (EH)]
<DOC> 119th CONGRESS 1st Session H. R. 6703
_______________________________________________________________________
AN ACT
To ensure access to affordable health insurance.
Be it enacted by the Senate a...
Related Topics
Healthcare & Insurance Reform
Generated using Llama 3.1 70B (Dr. Haus personality)
💰 Campaign Finance Network
Rep. Miller-Meeks, Mariannette [R-IA-1]
Congress 119 • 2024 Election Cycle
Total Contributions
$166,100
24 donors
PACs
$500
Organizations
$3,900
Committees
$0
Individuals
$160,200
1
POLITICAL COMMITTEE, NWF ACTION FUND
$500
1
US MARSHALS SERVICES
$2,900
2
HUNTON ANDREWS KURTH LLP
$1,000
No committee contributions found
1
SMITH, DYAN
$16,600
2
HOGAN, PATRICK F
$13,200
3
HOLDEN, RONALD
$13,200
4
VANDEWALLE, LOLA L
$13,200
5
GLEESON, JOHN W
$11,600
6
RICHARDS, DANIEL
$6,600
7
WILLOX, NORMAN
$6,600
8
PFAUTCH, ROY
$6,600
9
BRADLEY, JACQUELINE
$6,600
10
BROIN, JEFF MR.
$6,600
11
JAY, JEFFREY
$6,600
12
RICKETTS, J. JOE
$6,600
13
MCCOY, JUDITH
$6,600
14
SINGER, PAUL
$6,600
15
SABIN, ANDREW
$6,600
16
GILLIAM, RICHARD
$6,600
17
BELTRAME, MARC
$6,600
18
WOLL, MARGO
$6,600
19
SCHWARZMAN, CHRISTINE
$6,600
Donor Network - Rep. Miller-Meeks, Mariannette [R-IA-1]
PACs
Organizations
Individuals
Politicians
Hub layout: Politicians in center, donors arranged by type in rings around them.
Loading...
Showing 65 nodes and 25 connections (57 secondary connections hidden)
Total contributions: $166,100
Top Donors - Rep. Miller-Meeks, Mariannette [R-IA-1]
Showing top 24 donors by contribution amount
1 PAC2 Orgs2 Committees19 Individuals
Industry Impact
Which industries are materially affected by specific provisions in this bill. 4 helped, 1 harmed.
- −Pharmaceuticalsconfidence 0.90
Section 201 imposes new reporting requirements and oversight on pharmacy benefit management services, which are closely tied to pharmaceutical manufacturers and drug pricing. The bill requires entities providing pharmacy benefit management services to disclose detailed drug pricing and rebate information, increasing transparency and potentially reducing pharmaceutical manufacturers' ability to negotiate confidential rebates, which could negatively impact their revenue.
- +Health Insuranceconfidence 0.85
Section 101 expands association health plans, allowing more employers and self-employed individuals to form group health plans, which could increase enrollment in private health insurance options. Section 202 provides funding for cost-sharing reduction payments under the Affordable Care Act, which helps stabilize premiums and supports health insurers participating in the individual market.
- +Medical Devicesconfidence 0.80
Section 103 expands health reimbursement arrangements (HRAs) that can be used for medical care, which could increase utilization of medical devices as part of reimbursable expenses, benefiting medical device manufacturers.
- +Hospitals & Health Systemsconfidence 0.75
By expanding access to affordable health insurance through association health plans (Sec. 101) and funding cost-sharing reductions (Sec. 202), the bill likely increases the number of insured individuals, which could lead to higher patient volumes and more stable revenue for hospitals and health systems.
- +Biotech & Researchconfidence 0.70
Section 103's expansion of HRAs to cover individual market care may increase access to biotech therapies (e.g., gene therapies, specialty drugs) as reimbursable expenses, benefiting biotech firms.
Who funds the sponsor on these industries
For each industry this bill affects, here's what the sponsor (Rep. Miller-Meeks, Mariannette [R-IA-1])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.
Industries this bill HELPS
- Biotech & Research$3,420from 11 contributions
- BURT, DAVID$520
- ANDREWS, BLESSON$520
- RUSSELL, JOY$500
- LAIRD, MICHAEL$260
- STOLL, TOM$260
- from 2 contributions
- MARTIN, DAVID$250
- SIGMON, RICHARD$100
Industries this bill HARMS
- Pharmaceuticals$1,500from 3 contributions
- MARIN, DAVID$500
- WALLACE, PETE$500
- HERMANCE, ERIN$500